{"SPADE_N_13888": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_13888", "Peptide Name": "LBU1-31 (fragment of Lactolisterin BU, synthetic AMPs20; XXI; Derivative: LBU1-24)", "Source": "Sequence truncation, bacteria-derived, natural derivative", "Family": "Not found", "Gene": "Not found", "Sequence": "MWGRILGTVAKYGPKAVSWAWQHKWELINMG", "Sequence Length": 31, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 3615.24, "PI": 10.0, "Hydrophobicity": -0.17, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Malesevic M, Gardijan L, Miljkovic M, O'Connor PM, Mirkovic N, Jovcic B, Cotter PD, Jovanovic G, Kojic M. 2023", "Reference": "Lett Appl Microbiol. 2023 Jan 12:ovad004. doi: 10.1093/lambio/ovad004.", "Title": "Exploring the antibacterial potential of Lactococcus lactis subsp. lactis bv. diacetylactis BGBU1-4 by genome mining, bacteriocin gene overexpression, and chemical protein synthesis of lactolisterin BU variants."}], "Frequent Amino Acids": "GWA", "Absent Amino Acids": "CDFOU", "Basic Residues": 5, "Acidic Residues": 1, "Hydrophobic Residues": 17, "Polar Residues": 15, "Positive Residues": 5, "Negative Residues": 1, "Net Charge": 4, "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (72.09%) toLactolisterin BUMol Wt:  3615.282; GRAVY: -0.17; Mol Formula:  C170H258N44O39S2; mol ex coeff: 23690.Discovery: a breakdown peptide during purification of its parent peptide.Chemical modification: the N-terminal Met is N-formylated.Activity: active against L. lactis BGMN1-596 (MIC 64 ug/ml), S. aureus ATCC25923 (MIC 86.67 ug/ml), and L.monocytogenes ATCC19111 (MIC 158.33 ug/ml). Synthetic peptide showed similar activity.SAR: of note LBU1-24, a shorter synthetic peptide with 24 residues,is more active than LBU1-31.  Updated 9/2024", "Similar Sequences": [{"SPADE_ID": "SPADE_N_11848", "Similarity": 1.0, "Sequence": "MWGRILGTVAKYGPKAVSWAWQHKWELINMGDLAFRYIQRIWG"}, {"SPADE_ID": "SPADE_UN_25463", "Similarity": 1.0, "Sequence": "MWGRILGTVAKYGPKAVSWAWQHKWELINMG"}, {"SPADE_ID": "SPADE_UN_25464", "Similarity": 1.0, "Sequence": "MWGRILGTVAKYGPKAVSWAWQHK"}]}}}